Notice on investigator-initiated multicenter parallel-group clinical trial on HAL—HN-01 for rare-intractable spinal cord diseases to expand target diseases

CYBERDYNE

• PRODUCTS

  • WHAT'S HAL
  • MEDICAL HAL
  • -LOWER LIMB TYPE (EU)
  • -SINGLE JOINT TYPE (EU)
  • NON-MEDICAL HAL
  • -LOWER LIMB TYPE — WELL-BEING
  • -SINGLE JOINT TYPE — WELL-BEING
  • -LUMBAR TYPE — WELL-BEING (BB04)
  • -LUMBAR TYPE — WELL-BEING (FB02)
  • -LUMBAR TYPE — LABOR SUPPORT
  • HAL PERIPHERALS
  • CLEANING ROBOT
  • TRANSPORTATION ROBOT
  • ACOUSTIC X
  • CYIN FOR LIVING SUPPORT

• SERVICES

  • MEDICAL SERVICE
  • -CYBERNICS TREATMENT
  • NON-MEDICAL SERVICE
  • -NEURO HALFIT
  • -NEURO HAL PLUS
  • -NEURO HALFIT AT HOME

• STUDIO

  • CYBERDYNE STUDIO
  • -GROUP GUIDED TOUR
  • -HAL DEMONSTRATION

• ABOUT US

  • CORPORATE INFORMATION
  • INVESTOR RELATIONS
  • NEWS, EVENTS & MEDIA
  • C-STARTUP / CEJ FUND
  • SHAREHOLDERS BENEFIT
  • ABOUT US
  • ACCESS
  • CONTACT
  • CYBERDYNE
  • CYBERDYNE STUDIO